Kaituo Biotechnology (Suzhou) Co.
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- Undisclosed
Investors
- 6
About Kaituo Biotechnology (Suzhou) Co.
, Ltd. is a pharmaceutical company focusing on the technology development and application of gene therapy and nucleic acid drugs. The company established research and development centers and industrialization bases in Suzhou and Wuhan. The core team comes from Harvard University, University of California, Ohio State University, etc. In December 2022, it awarded Outstanding Enterprise in China Innovation and Entrepreneurship Competition., Ltd. The company provides one-stop CDMO services for the entire industry chain of gene cell therapy drugs and nucleic acid drugs from drug research and development, quality research, clinical application and industrialization. It has established three technical service platforms for large-scale plasmid process development and production, mRNA synthesis and delivery full-process process development and production, nucleic acid analysis methods and quality research. The company generates revenue by providing one-stop CRDMO services for gene cell therapy drugs and nucleic acid drugs. The company will use the strategic investment to strengthen technology in the field of nucleic acid drugs, expand overseas business, and improve customized services.
Who invested in Kaituo Biotechnology (Suzhou) Co.
6 investors across 1 round
See all investors in Kaituo Biotechnology (Suzhou) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 25, 2022
Amount
Undisclosed
Investors
Questions about Kaituo Biotechnology (Suzhou) Co.
Who invested in Kaituo Biotechnology (Suzhou) Co.?
Kaituo Biotechnology (Suzhou) Co. has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kaituo Biotechnology (Suzhou) Co. raised?
Kaituo Biotechnology (Suzhou) Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kaituo Biotechnology (Suzhou) Co. last raise money?
Kaituo Biotechnology (Suzhou) Co.'s most recent round on record is a Series A, in Apr 2022.
What does Kaituo Biotechnology (Suzhou) Co. do?
Kaituo Biotechnology (Suzhou) Co. is a biotechnology company.
Where is Kaituo Biotechnology (Suzhou) Co. headquartered?
Kaituo Biotechnology (Suzhou) Co. is headquartered in Suzhou, China.
Which VCs invest in companies like Kaituo Biotechnology (Suzhou) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Kaituo Biotechnology (Suzhou) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kaituo Biotechnology (Suzhou) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.